WisdomTree BioRevolution Fund
WDNA
#3770
ETF rank
HK$39.08 M
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
HK$186.12
Share price
2.57%
Change (1 day)
47.92%
Change (1 year)

WisdomTree BioRevolution Fund - Holdings

Etf holdings as of November 6, 2026Number of holdings: 83

Full holdings list

Weight %Name
3.74%
Tempus Ai Inc
3.64%
Eli Lilly & Co
3.39%
Moderna Inc
3.00%
Twist Bioscience Corp
2.93%
Immunome Inc
2.56%
Thermo Fisher Scientific Inc
2.38%
Natera Inc
2.33%
Stoke Therapeutics Inc
2.14%
United Therapeutics Corp
1.92%
10X Genomics Inc-Class A
1.90%
Vertex Pharmaceuticals Inc
1.81%
Amgen Inc
1.81%
Gilead Sciences Inc
1.78%
Cg Oncology Inc
1.75%
Roivant Sciences Ltd
1.68%
Revolution Medicines Inc
1.65%
ASTRAZENECA PLC
1.59%
Bayer AG
1.55%
Darling Ingredients Inc
1.53%
Crispr Therapeutics Ag
1.50%
Pfizer Inc
1.49%
Vylor Inc
1.47%
Beam Therapeutics Inc
1.46%
Xencor Inc
1.42%
Krystal Biotech Inc
1.37%
Dyne Therapeutics Inc
1.37%
Novozymes A/S
1.33%
Oruka Therapeutics Inc
1.30%
Prime Medicine Inc
1.26%
Novartis AG
1.21%
Biohaven Ltd
1.20%
Bridgebio Pharma Inc
1.20%
Exelixis Inc
1.12%
Agios Pharmaceuticals Inc
1.10%
ABSCI Corp
1.10%
Vir Biotechnology Inc
1.06%
UNIQURE NV
1.05%
Praxis Precision Medicines I
1.05%
Structure Therapeutics Inc
1.01%
Protagonist Therapeutics Inc
0.97%
Wave Life Sciences Inc
0.96%
Arrowhead Pharmaceuticals Inc
0.96%
4D Molecular Therapeutics In
0.96%
Argenx Se - Adr
0.95%
Rocket Pharmaceuticals Inc
0.95%
Intellia Therapeutics Inc
0.92%
Caris Life Sciences Inc
0.91%
Grail Inc
0.87%
Ideaya Biosciences Inc
0.86%
Biogen Idec Inc
0.85%
Ionis Pharmaceuticals Inc
0.85%
Repligen Corp
0.83%
Danaher Corp
0.78%
Halozyme Therapeutics Inc
0.77%
Biontech Se-ADR
0.76%
Arcturus Therapeutics Hlgs
0.74%
Genmab A/S -Sp ADR
0.73%
Celldex Therapeutics Inc
0.73%
Alnylam Pharmaceuticals Inc
0.72%
Merck & Co Inc/NJ
0.71%
Regeneron Pharmaceuticals Inc
0.69%
Nurix Therapeutics Inc
0.66%
Editas Medicine Inc
0.66%
OXFORD NANOPORE TECHNOLOGIES
0.63%
Iovance Biotherapeutics Inc
0.63%
SYENSQO SA
0.60%
Illumina Inc
0.59%
Viking Therapeutics Inc
0.59%
Cullinan Therapeutics Inc
0.57%
Insmed Inc
0.56%
Qiagen N.V.
0.55%
Nufarm Ltd/Australia
0.54%
Genus Plc
0.54%
Veracyte Inc
0.53%
Zoetis Inc
0.51%
Verbio AG
0.51%
BioMarin Pharmaceutical Inc
0.50%
Regenxbio Inc
0.50%
Neuropace Inc
0.49%
Ultragenyx Pharmaceutical Inc
0.46%
Green Plains Inc
0.40%
Geron Corp
0.37%
Allogene Therapeutics Inc